LITHMAX
LITHMAX
Approved
DIN Number
02266695
Drug Class
Human
Market Date
Apr 6, 2005
Company
HC
aa pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02266695
AIG Number0101163002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AN01 LITHIUM
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LITHIUM CARBONATEActive
Strength: 300 MG
Monograph: LITHIUM CARBONATE